Download Free Sample Report

Mammalian Cells are regularly used in the?biopharmaceutical industry?for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry.
This report contains market size and forecasts of Mammalian Cell Banking in Global, including the following market information:

• Global Mammalian Cell Banking Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Mammalian Cell Banking market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Master Cell Banks Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mammalian Cell Banking include Sartorius Stedim BioOutsource Limited., Charles River Laboratories., Eurofins DiscoverX Corporation, Merck KGaA, Lonza Group Ltd, VIRUSURE, Altogen Labs, Abzena Ltd and Northway Biotechpharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mammalian Cell Banking companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mammalian Cell Banking Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mammalian Cell Banking Market Segment Percentages, by Type, 2021 (%)

• Master Cell Banks
• Working Cell Banks
• End of Production Cell Banks
• Research & Development Cell Banks
• Others

Global Mammalian Cell Banking Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Mammalian Cell Banking Market Segment Percentages, by Application, 2021 (%)

• Academic & Research Laboratories
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Others

Global Mammalian Cell Banking Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Mammalian Cell Banking Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Mammalian Cell Banking revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Mammalian Cell Banking revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sartorius Stedim BioOutsource Limited.
• Charles River Laboratories.
• Eurofins DiscoverX Corporation
• Merck KGaA
• Lonza Group Ltd
• VIRUSURE
• Altogen Labs
• Abzena Ltd
• Northway Biotechpharma
• Selexis SA